ELI LILLY & Co — Director's Dealing 2020

Feb 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2020-02-16

Reporting Person: Norton Johna (Senior VP, Global Quality)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-16	Common Stock	M	97	—	Acquired	162	Indirect
2020-02-16	Common Stock	F	34	$141.12	Disposed	128	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-16	Restricted Stock Unit	$	M	97	Disposed	2020-02-16	Common Stock (97.0)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2595	Indirect
Common Stock	22401	Direct
Common Stock	499	Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.